about
Automation bias in electronic prescribingDepression screening via a smartphone app: cross-country user characteristics and feasibility.A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care settingPrevalence, prescribing and barriers to effective management of hypertension in older populations: a narrative reviewMulticenter study of voriconazole pharmacokinetics and therapeutic drug monitoring.A systematic review of the outcomes reported in trials of medication review in older patients: the need for a core outcome set.Measuring anticholinergic drug exposure in older community-dwelling Australian men: a comparison of four different measuresMulticenter study of posaconazole therapeutic drug monitoring: exposure-response relationship and factors affecting concentration.Impact of Hospitalization on Antihypertensive Pharmacotherapy among Older PersonsDoes a Mobile Phone Depression-Screening App Motivate Mobile Phone Users With High Depressive Symptoms to Seek a Health Care Professional's Help?Drug metabolism in older people--a key consideration in achieving optimal outcomes with medicines.Attitudes of pharmacists to provision of Home Medicines Review for Indigenous Australians.Hypertension in Older Persons: A Systematic Review of National and International Treatment Guidelines.Safety and effectiveness of palliative drug treatment in the last days of life - a systematic literature review.Drug utilization and medication costs at the end of life.Effect of humour therapy on psychotropic medication use in nursing homes.Nurse practitioner prescribing in Australia: A comprehensive literature review.Cross-national comparison of medication use in Australian and Dutch nursing homes.Laxative Use and Self-Reported Constipation in a Community-Dwelling Elderly Population: A Community-Based Survey From Australia.The use of antipsychotics among people treated with medications for dementia in residential aged care facilities.Safety of opioid patch initiation in Australian residential aged care.A longitudinal study of constipation and laxative use in a community-dwelling elderly population.Terbinafine in combination with other antifungal agents for treatment of resistant or refractory mycoses: investigating optimal dosing regimens using a physiologically based pharmacokinetic model.Medication Safety: an audit of medication discrepancies in transferring type 2 diabetes mellitus (T2DM) patients from Australian primary care to tertiary ambulatory care.Validity of performance indicators for assessing prescribing quality: the case of asthma.Antidepressant switching patterns in the elderly.Validity of prescribing indicators for assessing quality of antibiotic use in Australian general practice.Relationship between guideline treatment and health-related quality of life in asthma.Challenges in the Management of Hypertension in Older Populations.Prevalence, management and control of hypertension in older adults on admission to hospitalCompliance with pathology testing guidelines in Australian general practice: protocol for a secondary analysis of electronic health record dataNurse practitioner prescribing practice in Australia: confidence in aspects of medication managementLeveraging new information technology to monitor medicine use in 71 residential aged care facilities: variation in polypharmacy and antipsychotic useAppropriate Use of Laxatives in the Older Person
P50
Q30842233-35B88B9C-277E-4B3A-9AAF-8E2033D5D61DQ33441872-3AB94AB9-DF2E-4A7B-ACDF-E15834BCB087Q34637462-7DFBDEF3-17EF-4B4A-95F7-AA96C78E8550Q36165720-099C2DF1-418B-43B0-894A-460225B4410BQ36172497-1DC8E628-DE2E-4DCD-8722-5A47D1177E8EQ36205093-6C821AF6-CC5A-4D89-A799-0485BEBEDAB7Q36243682-3DE04315-0F39-4D53-9DCF-33A5343C3FABQ36364013-CF1E0F99-1083-4C01-9B27-BE11DC182DB9Q36942911-D2B1AA40-2661-4585-911D-D17E303C431EQ37130858-633CE80E-D6A1-4369-90E6-5383C76CB0CEQ37915843-CEF3F25E-5860-4627-9BBB-DA7215463F8BQ38260828-90E3B623-2C75-4C54-8E13-EBA89AD7E72CQ38397552-375B7FEA-98F3-4B3E-A7C2-91C8F3F2AC52Q38627400-C03C1D70-8F09-4396-926D-0C615F2D4DB5Q38751597-0E6E18CA-95BD-4E7E-9BD7-CC1D8BB06992Q38780119-3BDD6BF2-CF32-41F5-9584-A80E8F517C5CQ39027560-632CB0D9-D210-4C69-82AE-1C8F3DE14906Q39100664-3499BD35-6096-4594-982B-CBB80708F5FDQ39525725-A14F1EEE-5F6C-4128-ADF7-2FE7D83BB411Q40099193-CC42BEC3-2856-45E7-B32D-B8B42F9B2D3EQ40480672-298AEFBA-D5A2-417B-A654-DF057E28624FQ41305211-10B5DD3F-2E1E-4550-9AE1-FDC433AD4843Q41907385-FDB7DDC6-C4D1-416D-9767-D0151AFD82E0Q43571345-FEAAEE1E-4650-42FF-9190-490ABFB1AE0FQ47378152-3D3CFAA7-38C7-4BF1-8EF2-700907611ABBQ48143618-FD4E759C-A8DA-4F52-95FD-E3F562D9BEB5Q48765798-790C3C2C-F51A-4DFB-A2FA-310D2C20CFB6Q53288897-ED954E1D-DC71-4921-A184-04C142E8D054Q53555397-FD24AC43-58ED-4596-8FB1-653C9F72467BQ57925737-5950FF6A-5AE1-470C-93E7-ACFA6E02DDD0Q59808243-E0FA1F24-A049-4795-BF17-67A30429BE32Q87381575-B96D9FC1-13FD-45FB-8F1C-E92C4D9FEB09Q89061121-E79F75A2-86BE-49A4-917C-88C4F5519EF4Q93066344-12CC7799-CF80-4588-B3EA-161904007C45
P50
subject
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Lisa G Pont
@ast
Lisa G Pont
@en
Lisa G Pont
@es
Lisa G Pont
@nl
Lisa G Pont
@sl
type
label
Lisa G Pont
@ast
Lisa G Pont
@en
Lisa G Pont
@es
Lisa G Pont
@nl
Lisa G Pont
@sl
prefLabel
Lisa G Pont
@ast
Lisa G Pont
@en
Lisa G Pont
@es
Lisa G Pont
@nl
Lisa G Pont
@sl
P1006
P214
P1006
P106
P21
P213
0000 0003 8785 5943
P214
P31
P496
0000-0002-8545-716X
P734
P735
P7859
viaf-280881750